Transparency Market Research provides vital insights on the global 3D bioprinting market in its upcoming report, titled “Global 3D Bioprinting Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025.” TMR expects that the 3D bioprinting market will witness rapid growth during the forecast period owing to the rising demand for high-throughput 3D-bioprinted tissue models for research and drug discovery.

3D printing, also known as additive manufacturing, has harbored several innovations in diverse areas of medicine, manufacturing, engineering, and education. Bioprinting is the 3D printing of various biocompatible materials, including cells and components, into three dimensional functional living tissues. 3D bioprinting is relatively an emerging domain but has made rapid advances in the last decade. The domain encapsulates numerous disciplines that may include biomaterials sciences, cell biology, engineering, and physics. 3D bioprinting processes can be employed by researchers and cell biology experts to develop a wide range of tissues of any designs and size, such as multilayered skin, bones, tracheal splints, cardiac tissue, cartilaginous structure, and vascular grafts. The micro-scale tissue structure produced by 3D printing is widely used in cell study.

The constant pace of technological advances in the pharmaceutical and biotechnology sectors is underpinning the growth of the market. The need for advanced drug screening tests has led 3D bioprinting act as a promising candidate in toxicology. This is catalyzing the growth of the 3D bioprinting market. The vast potential of 3D printing process in regenerative therapies, such as for generation and transplantation of tissues, accounts for the lucrativeness of the market in the medical sector. The rapid inroads made by regenerative medicines in various parts of the world is supporting the market growth.

The reduction in the cost of 3D printers in recent years had helped in the rapid expansion of the 3D bioprinting market. However, the equipment used for 3D bioprinting is still unaffordable to emerging economies at large. Relentless research to bring improvements in 3D bioprinting are unlocking promising prospects in the market. Furthermore, rapid advances made in biotechnology in developed nations is also supporting the expansion of the 3D bioprinting market. The trend of personalized medicine will also impart a remarkable momentum to the growth of the market.

To give a better competitive landscape, TMR has included some of the prominent players operating in the market and these are TeVido BioDevices, Rainbow Biosciences, 3D Systems, Inc., regenHU, EnvisionTEC GmbH, Stratasys Ltd., nScrypt, Inc., Regenovo Biotechnology Co., GeSiM, and Aspect Biosystems Ltd.

About Us  

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com